INDIA IPO
  • Home
  • About
    • About us
    • Our CSR
  • Services

    IPO

    • Initial Public Offering (IPO)
    • SME IPO Consultation
    • Mainline IPO Consultation
    • Follow-On Public Offer (FPO)
    • Pre-IPO Funding Consultants

    Capital Raising

    • Social Stock Exchange
    • Private Placement
    • Project Funding
    • REIT
    • SM REIT
    • Rights Issue Advisory
    • InvIT Rights Issue
    • InvIT Public Issue
    • InvIT Private Issue
    • Debt Syndication
    • Securitised Debt Instruments
    • Public Municipal Debt
    • Private Municipal Debt

    Finance Advisory

    • Business Valuation
    • Corporate Finance
    • Financial Modelling
    • Project Finance
  • Investors
  • Merchant Bankers

    SME

    • List of SME Merchant Bankers

    MAINBOARD

    • List of Mainboard Merchant Bankers
  • Resources

    Reports

    • Daily Reporter
    • IPO Calendar
    • Upcoming IPO Calendar
    • Mainline IPO Report
    • SME IPO Report
    • SME IPOs by Sector
    • Mainboard IPOs by Sector

    IPO Knowledge

    • IPO World Magazine
    • IPO Process
    • Pre-IPO Process Guidance
    • IPO Blogs
    • Sector Wise IPO List In India
    • List of IPO Registrar

    Notifications / Circulars

    • SEBI ICDR Amendment Regulations 10.03.2025
    • SEBI SME IPO ICDR Amendments report 10.03.25
    • ICDR
    • BSE SME Eligibility Criteria
    • NSE Emerge Eligibility Criteria
  • News/Updates
    • Markets & Money Update
    • IPO & Market Snaps
  • Contact Us
  • Check IPO Feasibility
Check IPO Feasibility
INDIA IPO
INDIA IPO

Contact Info:

  • +91-96506-37280
  • +011-47008280
  • info@indiaipo.in
  • 808, 8thFloor D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034.
shape
  1. Home
  2. News
  3. Sastasundar Healthbuddy Limited Executes Share Purchase Agreement for 4.68% Stake Sale
ipo services in India
India IPO
  • 25 Feb 2026
  • X
 Sastasundar Healthbuddy Limited Executes Share Purchase Agreement for 4.68% Stake Sale

Health X Platform Limited disclosed that its material subsidiary Sastasundar Healthbuddy Limited executed a Share Purchase Agreement on February 25, 2026. Envision India Fund will acquire 10,13,766 equity shares (4.68% stake) from Mitsubishi Corporation at Rs. 493.21 per share, totaling Rs. 49,99,99,528.86. The transaction is subject to agreed conditions and will result in Mitsubishi Corporation ceasing to be a shareholder of SHBL.

Sastasundar Healthbuddy Limited Executes Share Purchase Agreement for 4.68% Stake Sale

Sastasundar ventures has announced a significant share transaction involving its material subsidiary Sastasundar Healthbuddy Limited (SHBL). The company disclosed under Regulation 30 of SEBI regulations that a Share Purchase Agreement was executed on February 25, 2026, facilitating a stake transfer between institutional investors. Transaction Details The share purchase agreement involves three parties: Sastasundar Healthbuddy Limited, Mitsubishi Corporation as the seller, and Envision India Fund as the buyer. The transaction parameters are structured as follows: Parameter: Details Shares to be transferred: 10,13,766 equity shares Stake percentage: 4.68% of total issued and paid-up share capital Price per share: Rs. 493.21 Total consideration: Rs. 49,99,99,528.86 Seller: Mitsubishi Corporation Buyer: Envision India Fund Regulatory Compliance Health X Platform Limited, formerly known as Sastasundar Ventures Limited, received the transaction intimation from its material subsidiary SHBL on February 25, 2026 at 7:57 P.M. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Impact on Shareholding Structure Upon completion of this acquisition, Mitsubishi Corporation will cease to be a shareholder of Sastasundar Healthbuddy Limited. The transaction is subject to the satisfaction of agreed terms and conditions as stipulated in the Share Purchase Agreement. Envision India Fund will acquire the 4.68% stake, representing a significant institutional investment in the healthcare subsidiary. Corporate Structure Sastasundar Healthbuddy Limited operates as a material subsidiary of Health X Platform Limited. The parent company maintains its listing status and continues to fulfill disclosure obligations regarding material developments in its subsidiaries. The transaction demonstrates ongoing investor interest in the healthcare technology sector, with institutional funds actively participating in stake acquisitions. Sastasundar ventures has disclosed multiple share acquisitions by its promoter under SEBI insider trading regulations. The company has informed BSE and NSE about these transactions through formal disclosures, demonstrating continued promoter confidence in the company. Recent Promoter Share Acquisitions Promoter Banwari Lal Mittal has made two separate acquisitions of equity shares through market purchases. The first transaction was executed on 11.02.2026, followed by another acquisition on 18.02.2026, both intimated to the company on their respective transaction dates. Parameter: First Transaction Second Transaction Promoter Name: Banwari Lal Mittal Banwari Lal Mittal PAN: ADMPM0065G ADMPM0065G DIN: 00365809 00365809 Transaction Date: 11.02.2026 18.02.2026 Intimation Date: 11.02.2026 18.02.2026 Disclosure Date: 13.02.2026 19.02.2026 Transaction Summary The market purchases involved a total of 13,000 equity shares across two transactions with a combined transaction value of Rs. 38,68,525.02, inclusive of taxes. These acquisitions represent a strategic increase in the promoter's stake in the company. Transaction: Shares Acquired Transaction Value Shareholding Before Shareholding After First Purchase: 8,000 Rs. 24,13,008.89 33.7580% 33.7832% Second Purchase: 5,000 Rs. 14,55,517.13 33.7832% 33.7989% Total Impact: 13,000 Rs. 38,68,525.02 33.7580% 33.7989% Progressive Shareholding Changes The cumulative effect of both transactions shows a steady increase in promoter shareholding, reflecting continued confidence in the company's prospects. Metric: Initial Position After First Transaction After Second Transaction Total Change Number of Shares: 1,07,38,603 1,07,46,603 1,07,51,603 +13,000 Shareholding %: 33.7580% 33.7832% 33.7989% +0.0409% Regulatory Compliance Both disclosures were made pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Company Secretary and Compliance Officer Pratap Singh submitted the required Form C to both BSE (Stock Code: 533259) and NSE (Symbol: SASTASUNDR) for each transaction. The company confirmed that no derivative trading was involved in either transaction, with all derivative-related fields marked as "N.A." in the regulatory filings. These acquisitions strengthen the promoter's position in Sastasundar Ventures Limited while maintaining full regulatory compliance throughout both transactions. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

Recent News

E2E Networks launches QIP issue, floor price set at ₹2,630.60 per share
e2e-networks-launches-qip-issue-floor-price-set-at-rs263060-...
25 Feb 2026
Gconnect Logitech and Supply Chain Limited Schedules Board Meeting on March 02, 2026 for Preferential Equity Issuance
gconnect-logitech-and-supply-chain-limited-schedules-board-m...
25 Feb 2026
Themis Medicare Approves Preferential Issue of 45,95,795 Convertible Equity Warrants at Rs. 100 Each
themis-medicare-approves-preferential-issue-of-4595795-conve...
25 Feb 2026
Zen Technologies Transfers 1,860 Equity Shares to Employees Under ESOP-2021 Scheme
zen-technologies-transfers-1860-equity-shares-to-employees-u...
25 Feb 2026
USD 105 trillion raised through equity and debt issuances in 10 years: SEBI Chief
usd-105-trillion-raised-through-equity-and-debt-issuances-in...
25 Feb 2026
SEBI's Resilience: Indian Market's $105 Trillion Surge Through Equity and Debt
sebis-resilience-indian-markets-105-trillion-surge-through-e...
25 Feb 2026
Facebook Overseas acquires 30% stake in RIL firm for ₹257 crore
facebook-overseas-acquires-30-stake-in-ril-firm-for-rs257-cr...
25 Feb 2026
Clean Max's IPO Receives 94% Subscription: Paving the Way for Greener Investments
clean-maxs-ipo-receives-94-subscription-paving-the-way-for-g...
25 Feb 2026
Accord Transformer, Mobilise App Lab IPOs attract robust demand but Kiaasa Retail sees muted response on final day
accord-transformer-mobilise-app-lab-ipos-attract-robust-dema...
25 Feb 2026
Reliance Industries announces REIL stake restructuring, Meta picks 30% stake
reliance-industries-announces-reil-stake-restructuring-meta-...
25 Feb 2026
pre ipo advisory services in India
  • GST No: 07AAHCB7068H2ZF

India IPO is a leading Indian business services platform that helps firms and companies to launch their initial public offerings (IPOs) in order to raise essential capital for growth and expansion while adding value & fueling the nation’s immense potential and future opportunities.

Follow us:

Facebook Twitter LinkedIn Instagram YouTube

Quick Links

  • Home
  • Blogs
  • Consultant
  • Youtube Videos
  • News
  • Contact Us
  • Career

Our Services

  • IPO Process

Other Links

  • Disclaimer
  • Privacy & Policy
  • Sitemap

Contact Information:

  • Corporate Office: 808, 8th Floor, D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034
  • Regional Office: Office No. 601, Shagun Insignia, Ulwe, Sector-19, Navi Mumbai- 410206
  • Email: info@indiaipo.in
  • Mobile: +91-74283-37280, +91-96509-82781
  • Disclaimer  |
  • Privacy & Policy  |
  • Terms & Conditions  

Copyright © All right reserved by - Bmarkt Tecamat Private Limited